EQ-5D-5L data | Intervention | Unadjusted cost (£) (95% CI) | Adjusted* incremental cost (£) (95% CI) | Unadjusted† QALY (95% CI) | Adjusted incremental QALY (95% CI) | ICER (ΔCost/ ΔQALY) (£) | Probability of being cost-effective at different thresholds for a QALY | |||
£0 | £20 000 | £30 000 | £50 000 | |||||||
Complete case data (n=290) | Trabeculectomy (n=144) | 3686 (3435 to 3937) | 2089 (1762 to 2416) | 1.65 (1.61 to 1.69) | 0.03 (0.01 to 0.08) | 64 303 | 0 | 0% | 6% | 35% |
Medical management (n=146) | 1605 (1390 to 1820) | 1.59 (1.55 to 1.64) | 100% | 100% | 94% | 65% | ||||
Imputation data (n=403) | Trabeculectomy (n=199) | 3622 (3372 to 3872) | 2013 (1699 to 2327) | 1.61 (1.57 to 1.65) | 0.04 (−0.01 to 0.08) | 45 456 | 0 | 0% | 12% | 56% |
Medical management (n=204) | 1605 (1409 to 1801) | 1.56 (1.52 to 1.60) | 100% | 100% | 88% | 44% |
*Adjusted results are based on the results of the SUREG.
†Unadjusted results are based on the trial data.
ICER, Incremental Cost-Effectiveness Ratio ; QALY, Quality-Adjusted Life-Year.